Chapter/Section Purchase

1 Study Coverage
1.1 Biological Multiplex Assays Revenue in Biological Multiplex Assays Business (2017-2022) & (US$ Million) Introduction
1.2 Global Biological Multiplex Assays Outlook 2017 VS 2022 VS 2028
1.2.1 Global Biological Multiplex Assays Market Size for the Year 2017-2028
1.2.2 Global Biological Multiplex Assays Market Size for the Year 2017-2028
1.3 Biological Multiplex Assays Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Biological Multiplex Assays in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Biological Multiplex Assays Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Biological Multiplex Assays Market Dynamics
1.4.1 Biological Multiplex Assays Industry Trends
1.4.2 Biological Multiplex Assays Market Drivers
1.4.3 Biological Multiplex Assays Market Challenges
1.4.4 Biological Multiplex Assays Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Biological Multiplex Assays by Type
2.1 Biological Multiplex Assays Market Segment by Type
2.1.1 Protein Assays
2.1.2 Nucleic Acid Assays
2.2 Global Biological Multiplex Assays Market Size by Type (2017, 2022 & 2028)
2.3 Global Biological Multiplex Assays Market Size by Type (2017-2028)
2.4 United States Biological Multiplex Assays Market Size by Type (2017, 2022 & 2028)
2.5 United States Biological Multiplex Assays Market Size by Type (2017-2028)
3 Biological Multiplex Assays by Application
3.1 Biological Multiplex Assays Market Segment by Application
3.1.1 Research And Development
3.1.2 Clinical Diagnosis
3.2 Global Biological Multiplex Assays Market Size by Application (2017, 2022 & 2028)
3.3 Global Biological Multiplex Assays Market Size by Application (2017-2028)
3.4 United States Biological Multiplex Assays Market Size by Application (2017, 2022 & 2028)
3.5 United States Biological Multiplex Assays Market Size by Application (2017-2028)
4 Global Biological Multiplex Assays Competitor Landscape by Company
4.1 Global Biological Multiplex Assays Market Size by Company
4.1.1 Top Global Biological Multiplex Assays Companies Ranked by Revenue (2021)
4.1.2 Global Biological Multiplex Assays Revenue by Player (2017-2022)
4.2 Global Biological Multiplex Assays Concentration Ratio (CR)
4.2.1 Biological Multiplex Assays Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Biological Multiplex Assays in 2021
4.2.3 Global Biological Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Biological Multiplex Assays Headquarters, Revenue in Biological Multiplex Assays Business (2017-2022) & (US$ Million) Type
4.3.1 Global Biological Multiplex Assays Headquarters and Area Served
4.3.2 Global Biological Multiplex Assays Companies Revenue in Biological Multiplex Assays Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Biological Multiplex Assays Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Biological Multiplex Assays Market Size by Company
4.5.1 Top Biological Multiplex Assays Players in United States, Ranked by Revenue (2021)
4.5.2 United States Biological Multiplex Assays Revenue by Players (2020, 2021 & 2022)
5 Global Biological Multiplex Assays Market Size by Region
5.1 Global Biological Multiplex Assays Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Biological Multiplex Assays Market Size by Region (2017-2028)
5.2.1 Global Biological Multiplex Assays Market Size by Region: 2017-2022
5.2.2 Global Biological Multiplex Assays Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Biological Multiplex Assays Market Size YoY Growth 2017-2028
6.1.2 North America Biological Multiplex Assays Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Biological Multiplex Assays Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Biological Multiplex Assays Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Biological Multiplex Assays Market Size YoY Growth 2017-2028
6.3.2 Europe Biological Multiplex Assays Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Biological Multiplex Assays Market Size YoY Growth 2017-2028
6.4.2 Latin America Biological Multiplex Assays Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Biological Multiplex Assays Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Biological Multiplex Assays Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Luminex
7.1.1 Luminex Company Details
7.1.2 Luminex Business Overview
7.1.3 Luminex Biological Multiplex Assays Introduction
7.1.4 Luminex Revenue in Biological Multiplex Assays Business (2017-2022)
7.1.5 Luminex Recent Development
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Details
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Biological Multiplex Assays Introduction
7.2.4 Thermo Fisher Scientific Revenue in Biological Multiplex Assays Business (2017-2022)
7.2.5 Thermo Fisher Scientific Recent Development
7.3 Illumina
7.3.1 Illumina Company Details
7.3.2 Illumina Business Overview
7.3.3 Illumina Biological Multiplex Assays Introduction
7.3.4 Illumina Revenue in Biological Multiplex Assays Business (2017-2022)
7.3.5 Illumina Recent Development
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Company Details
7.4.2 Bio-Rad Laboratories Business Overview
7.4.3 Bio-Rad Laboratories Biological Multiplex Assays Introduction
7.4.4 Bio-Rad Laboratories Revenue in Biological Multiplex Assays Business (2017-2022)
7.4.5 Bio-Rad Laboratories Recent Development
7.5 Qiagen
7.5.1 Qiagen Company Details
7.5.2 Qiagen Business Overview
7.5.3 Qiagen Biological Multiplex Assays Introduction
7.5.4 Qiagen Revenue in Biological Multiplex Assays Business (2017-2022)
7.5.5 Qiagen Recent Development
7.6 Abcam
7.6.1 Abcam Company Details
7.6.2 Abcam Business Overview
7.6.3 Abcam Biological Multiplex Assays Introduction
7.6.4 Abcam Revenue in Biological Multiplex Assays Business (2017-2022)
7.6.5 Abcam Recent Development
7.7 Becton Dickinson
7.7.1 Becton Dickinson Company Details
7.7.2 Becton Dickinson Business Overview
7.7.3 Becton Dickinson Biological Multiplex Assays Introduction
7.7.4 Becton Dickinson Revenue in Biological Multiplex Assays Business (2017-2022)
7.7.5 Becton Dickinson Recent Development
7.8 Merck
7.8.1 Merck Company Details
7.8.2 Merck Business Overview
7.8.3 Merck Biological Multiplex Assays Introduction
7.8.4 Merck Revenue in Biological Multiplex Assays Business (2017-2022)
7.8.5 Merck Recent Development
7.9 Agilent Technologies
7.9.1 Agilent Technologies Company Details
7.9.2 Agilent Technologies Business Overview
7.9.3 Agilent Technologies Biological Multiplex Assays Introduction
7.9.4 Agilent Technologies Revenue in Biological Multiplex Assays Business (2017-2022)
7.9.5 Agilent Technologies Recent Development
7.10 Meso Scale Diagnostics
7.10.1 Meso Scale Diagnostics Company Details
7.10.2 Meso Scale Diagnostics Business Overview
7.10.3 Meso Scale Diagnostics Biological Multiplex Assays Introduction
7.10.4 Meso Scale Diagnostics Revenue in Biological Multiplex Assays Business (2017-2022)
7.10.5 Meso Scale Diagnostics Recent Development
7.11 Randox Laboratories
7.11.1 Randox Laboratories Company Details
7.11.2 Randox Laboratories Business Overview
7.11.3 Randox Laboratories Biological Multiplex Assays Introduction
7.11.4 Randox Laboratories Revenue in Biological Multiplex Assays Business (2017-2022)
7.11.5 Randox Laboratories Recent Development
7.12 Quanterix
7.12.1 Quanterix Company Details
7.12.2 Quanterix Business Overview
7.12.3 Quanterix Biological Multiplex Assays Introduction
7.12.4 Quanterix Revenue in Biological Multiplex Assays Business (2017-2022)
7.12.5 Quanterix Recent Development
7.13 Bio-Techne
7.13.1 Bio-Techne Company Details
7.13.2 Bio-Techne Business Overview
7.13.3 Bio-Techne Biological Multiplex Assays Introduction
7.13.4 Bio-Techne Revenue in Biological Multiplex Assays Business (2017-2022)
7.13.5 Bio-Techne Recent Development
7.14 Olink
7.14.1 Olink Company Details
7.14.2 Olink Business Overview
7.14.3 Olink Biological Multiplex Assays Introduction
7.14.4 Olink Revenue in Biological Multiplex Assays Business (2017-2022)
7.14.5 Olink Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer